Rehman_2017_Arch.Pharm.(Weinheim)_350_

Reference

Title : An Efficient Synthesis of bi-Aryl Pyrimidine Heterocycles: Potential New Drug Candidates to Treat Alzheimer's Disease - Rehman_2017_Arch.Pharm.(Weinheim)_350_
Author(s) : Rehman TU , Khan IU , Ashraf M , Tarazi H , Riaz S , Yar M
Ref : Arch Pharm (Weinheim) , 350 : , 2017
Abstract :

A series of 13 novel pyrimidine-based sulfonamides 6a-m were synthesized in short periods of time under microwave conditions in good to excellent yield (54-86%). The chemical structures of these heterocycles consist of a central pyrimidine ring having a phenyl group and pyrimidine groups with sulfonamide motifs. The enzyme inhibitory potential of these compounds was investigated against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) because these enzymes play a crucial role in the treatment of Alzheimer's disease. As compared to the reference compound eserine (IC50 = 0.04 +/- 0.0001 muM for AChE and IC50 = 0.85 +/- 0.0001 muM for BChE), the IC50 values of the synthesized compounds ranged from 3.73 +/- 0.61 muM to 57.36 +/- 0.22 muM for AChE and 4.81 +/- 0.16 muM to 111.61 +/- 0.53 muM for BChE. Among these tested compounds, 6j having a -CH3 group was found to be the most potent one against both enzymes (AChE, IC50 = 3.73 +/- 0.61 muM; BChE, IC50 = 4.81 +/- 0.16 muM). Quantitative structure-activity relationship (QSAR) and molecular docking studies of the synthesized compounds were also performed.

PubMedSearch : Rehman_2017_Arch.Pharm.(Weinheim)_350_
PubMedID: 28220522

Related information

Citations formats

Rehman TU, Khan IU, Ashraf M, Tarazi H, Riaz S, Yar M (2017)
An Efficient Synthesis of bi-Aryl Pyrimidine Heterocycles: Potential New Drug Candidates to Treat Alzheimer's Disease
Arch Pharm (Weinheim) 350 :

Rehman TU, Khan IU, Ashraf M, Tarazi H, Riaz S, Yar M (2017)
Arch Pharm (Weinheim) 350 :